C. A. Lipari

Learn More
The results reported support the use of IR imaging in risk assessment, detection, and as a prognostic indicator. We present preliminary evidence showing that the improvements in technology that have been incorporated into second-generation, focal-plane, indium-antimonide detector systems can significantly improve breast IR images.
In clinical testing it is standard to determine the normal range, and then to determine if a test can differentiate normal from diseased patients. Now with the advent of uncooled staring array digital infrared imaging systems (Prism 2000; Bioyear Group, Houston, TX) and image analysis, numerical results (mean temperatures of the whole breast and quadrants(More)
  • 1